By A Mystery Man Writer
Richard MESSMANN, Global Program Clinical Head GI/GU Solid Tumors, Doctor of Medicine, Novartis, Basel, Global Drug Development
Inhibition of APE1/Ref-1 redox activity rescues human retinal
Jill FEHRENBACHER, Professor (Assistant), Pharmacology and Toxicology
Apurinic/Apyrimidinic Endonuclease/Redox Factor-1 (APE1/Ref-1
Fenil SHAH, PostDoc Position, Indiana University School of Medicine, Indianapolis, IUSOM, Department of Pediatrics
APE1/Ref-1 as an emerging therapeutic target for various human
PDF) APE1/Ref-1 regulates PTEN expression mediated by Egr-1
BBR inhibited NO release and ROS production in LPS-stimulated
APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1
Richard MESSMANN, Global Program Clinical Head GI/GU Solid Tumors, Doctor of Medicine, Novartis, Basel, Global Drug Development
PDF) Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
Potential inhibitors of the Ref-1/APE1 signaling node and related
A: schematic representation of the redox signaling pathways that are